The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. AMGEN Inc shares valued at $434,520 were sold by Khosla Rachna on Jun 05 ’25. At $289.68 per share, Khosla Rachna sold 1,500 shares. The insider’s holdings dropped to 8,162 shares worth approximately $2.43 million following the completion of this transaction.
Also, Khosla Rachna purchased 1,500 shares, netting a total of over 435,000 in proceeds.
Before that, Busch Matthew C. had sold 1,000 shares from its account. In a trade valued at $279,690, the VP, Finance & CAO traded AMGEN Inc shares for $279.69 each. Upon closing the transaction, the insider’s holdings decreased to 1,000 shares, worth approximately $1.2 million.
Earlier on November 15, 2024, Wolfe Research initiated its rating. Their recommendation was “a Peer perform” for AMGN stock.
Analyzing AMGN Stock Performance
On last trading session,, AMGEN Inc [NASDAQ: AMGN] rose 1.88% to $297.29. The stock’s lowest price that day was $292.68, but it reached a high of $297.44 in the same session. During the last five days, there has been a surge of approximately 3.55%. Over the course of the year, AMGEN Inc shares have jumped approximately 14.06%.
Support And Resistance Levels for AMGEN Inc (AMGN)
RSI (Relative Strength Index) is 64.77 on the 14-day chart, showing neutral technical sentiment.
Is AMGEN Inc subject to short interest?
Stocks of AMGEN Inc saw a sharp steep in short interest on 2025-05-30 dropping by -1.68 million shares to 12.94 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 14.62 million shares. A decline of -12.99% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.11 of the overall float, the days-to-cover ratio (short ratio) decline to 4.11.
Which companies own the most shares of AMGEN Inc (AMGN)?
In terms of AMGEN Inc share price expectations, FactSet research, analysts set an average price target of 305 in the next 12 months, up nearly 4.52% from the previous closing price of $291.81. Analysts anticipate AMGEN Inc stock to reach 315 by 2025, with the lowest price target being 294. In spite of this, 19 analysts ranked AMGEN Inc stock as Buy at the end of 2025. On November 14, 2024, Citigroup assigned a price target of “a Neutral” to the stock and initiated coverage with a $335.
